Solutions
Business Development Live! – A Software Solution
Identify licensing opportunities
Asset Scouting
Benchmark Assets, Companies, Researchers
Consulting Services
Researcher and KOL Identification
Portfolio Optimization
Pre-Clinical Development Strategy
Financial Modeling and Net Present Value
About Relay
About Relay
Technology
Relay Innovation Engine (RIE)
The Relay Relative Value Index (RVI)
Management
Board of Directors
Advisory Board
News and Media
Press Releases
Relay In The News
Events
Relay Blog
Contact Us
Evaluate technologies and identify opportunities like never before
26th November 2011
Home Page Slider
READ MORE
Map competitive landscapes and identify opportunities
26th November 2011
Home Page Slider
READ MORE
Increase licensing revenue and new company formation
26th November 2011
Home Page Slider
READ MORE
Uncover opportunities and emerging trends in the BioPharma marketplace
26th November 2011
Home Page Slider
READ MORE
News and Media
Press Releases
Relay In The News
Events
Relay Blog
Topics
Analytics
Big Data
Deals
Emerging Markets
Events
Featured
Financings
Home Page Slider
IP
Licensing
New Technology
Personalized Medicine
Pipeline Analysis
Press Releases
Relay Blog
Relay In The News
Uncategorized
Venture
Tags
Alzheimer's
AstraZeneca
Bayer
Biogen
Biogen Idec
biotech
BMS
Boehringer
cancer
celgene
China
deal
Deals
diabetes
Drug Development
Eli Lilly
Genentech
genzyme
gsk
IPO
JnJ
licensing
lilly
merck
Merck KGaA
MS
Novartis
PacBio
Pfizer
pharma
pipeline
R&D
Relay 101
Roche
Sanofi
Sanofi-Aventis
Seattle Genetics
stem cells
Strategy
Takeda
Teva
third rock ventures
TRV
vaccine
Valeant
